The global market for Transarterial Radioembolization (TARE) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Transarterial Radioembolization (TARE) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Transarterial Radioembolization (TARE) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Transarterial Radioembolization (TARE) in Uterine Fibroid Embolization is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Transarterial Radioembolization (TARE) include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Transarterial Radioembolization (TARE), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transarterial Radioembolization (TARE).

The Transarterial Radioembolization (TARE) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transarterial Radioembolization (TARE) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Transarterial Radioembolization (TARE) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Transarterial Radioembolization (TARE) Market Report

Report Metric	Details
Report Name	Transarterial Radioembolization (TARE) Market
Segment by Type	Microspheres Particles Drug-eluting Beads (DEBs) Radio-Embolic Microspheres
Segment by Application	Uterine Fibroid Embolization Prostatic Artery Embolization Liver Tumor Embolization Trauma Embolization Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transarterial Radioembolization (TARE) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Transarterial Radioembolization (TARE) Market report?

Ans: The main players in the Transarterial Radioembolization (TARE) Market are Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical

What are the Application segmentation covered in the Transarterial Radioembolization (TARE) Market report?

Ans: The Applications covered in the Transarterial Radioembolization (TARE) Market report are Uterine Fibroid Embolization, Prostatic Artery Embolization, Liver Tumor Embolization, Trauma Embolization, Others

What are the Type segmentation covered in the Transarterial Radioembolization (TARE) Market report?

Ans: The Types covered in the Transarterial Radioembolization (TARE) Market report are Microspheres, Particles, Drug-eluting Beads (DEBs), Radio-Embolic Microspheres

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Transarterial Radioembolization (TARE) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Microspheres

1.2.3 Particles

1.2.4 Drug-eluting Beads (DEBs)

1.2.5 Radio-Embolic Microspheres

1.3 Market by Application

1.3.1 Global Transarterial Radioembolization (TARE) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Uterine Fibroid Embolization

1.3.3 Prostatic Artery Embolization

1.3.4 Liver Tumor Embolization

1.3.5 Trauma Embolization

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Transarterial Radioembolization (TARE) Market Perspective (2020-2031)

2.2 Global Transarterial Radioembolization (TARE) Growth Trends by Region

2.2.1 Global Transarterial Radioembolization (TARE) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Transarterial Radioembolization (TARE) Historic Market Size by Region (2020-2025)

2.2.3 Transarterial Radioembolization (TARE) Forecasted Market Size by Region (2026-2031)

2.3 Transarterial Radioembolization (TARE) Market Dynamics

2.3.1 Transarterial Radioembolization (TARE) Industry Trends

2.3.2 Transarterial Radioembolization (TARE) Market Drivers

2.3.3 Transarterial Radioembolization (TARE) Market Challenges

2.3.4 Transarterial Radioembolization (TARE) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Transarterial Radioembolization (TARE) Players by Revenue

3.1.1 Global Top Transarterial Radioembolization (TARE) Players by Revenue (2020-2025)

3.1.2 Global Transarterial Radioembolization (TARE) Revenue Market Share by Players (2020-2025)

3.2 Global Transarterial Radioembolization (TARE) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Transarterial Radioembolization (TARE) Revenue

3.4 Global Transarterial Radioembolization (TARE) Market Concentration Ratio

3.4.1 Global Transarterial Radioembolization (TARE) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Transarterial Radioembolization (TARE) Revenue in 2024

3.5 Global Key Players of Transarterial Radioembolization (TARE) Head office and Area Served

3.6 Global Key Players of Transarterial Radioembolization (TARE), Product and Application

3.7 Global Key Players of Transarterial Radioembolization (TARE), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Transarterial Radioembolization (TARE) Breakdown Data by Type

4.1 Global Transarterial Radioembolization (TARE) Historic Market Size by Type (2020-2025)

4.2 Global Transarterial Radioembolization (TARE) Forecasted Market Size by Type (2026-2031)

5 Transarterial Radioembolization (TARE) Breakdown Data by Application

5.1 Global Transarterial Radioembolization (TARE) Historic Market Size by Application (2020-2025)

5.2 Global Transarterial Radioembolization (TARE) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Transarterial Radioembolization (TARE) Market Size (2020-2031)

6.2 North America Transarterial Radioembolization (TARE) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Transarterial Radioembolization (TARE) Market Size by Country (2020-2025)

6.4 North America Transarterial Radioembolization (TARE) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Transarterial Radioembolization (TARE) Market Size (2020-2031)

7.2 Europe Transarterial Radioembolization (TARE) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Transarterial Radioembolization (TARE) Market Size by Country (2020-2025)

7.4 Europe Transarterial Radioembolization (TARE) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Transarterial Radioembolization (TARE) Market Size (2020-2031)

8.2 Asia-Pacific Transarterial Radioembolization (TARE) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Region (2020-2025)

8.4 Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Transarterial Radioembolization (TARE) Market Size (2020-2031)

9.2 Latin America Transarterial Radioembolization (TARE) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Transarterial Radioembolization (TARE) Market Size by Country (2020-2025)

9.4 Latin America Transarterial Radioembolization (TARE) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Transarterial Radioembolization (TARE) Market Size (2020-2031)

10.2 Middle East & Africa Transarterial Radioembolization (TARE) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2020-2025)

10.4 Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sirtex Medical

11.1.1 Sirtex Medical Company Details

11.1.2 Sirtex Medical Business Overview

11.1.3 Sirtex Medical Transarterial Radioembolization (TARE) Introduction

11.1.4 Sirtex Medical Revenue in Transarterial Radioembolization (TARE) Business (2020-2025)

11.1.5 Sirtex Medical Recent Development

11.2 Merit Medical

11.2.1 Merit Medical Company Details

11.2.2 Merit Medical Business Overview

11.2.3 Merit Medical Transarterial Radioembolization (TARE) Introduction

11.2.4 Merit Medical Revenue in Transarterial Radioembolization (TARE) Business (2020-2025)

11.2.5 Merit Medical Recent Development

11.3 Cook Medical

11.3.1 Cook Medical Company Details

11.3.2 Cook Medical Business Overview

11.3.3 Cook Medical Transarterial Radioembolization (TARE) Introduction

11.3.4 Cook Medical Revenue in Transarterial Radioembolization (TARE) Business (2020-2025)

11.3.5 Cook Medical Recent Development

11.4 BTG Medical

11.4.1 BTG Medical Company Details

11.4.2 BTG Medical Business Overview

11.4.3 BTG Medical Transarterial Radioembolization (TARE) Introduction

11.4.4 BTG Medical Revenue in Transarterial Radioembolization (TARE) Business (2020-2025)

11.4.5 BTG Medical Recent Development

11.5 Boston Scientific Corporation

11.5.1 Boston Scientific Corporation Company Details

11.5.2 Boston Scientific Corporation Business Overview

11.5.3 Boston Scientific Corporation Transarterial Radioembolization (TARE) Introduction

11.5.4 Boston Scientific Corporation Revenue in Transarterial Radioembolization (TARE) Business (2020-2025)

11.5.5 Boston Scientific Corporation Recent Development

11.6 Terumo Corporation

11.6.1 Terumo Corporation Company Details

11.6.2 Terumo Corporation Business Overview

11.6.3 Terumo Corporation Transarterial Radioembolization (TARE) Introduction

11.6.4 Terumo Corporation Revenue in Transarterial Radioembolization (TARE) Business (2020-2025)

11.6.5 Terumo Corporation Recent Development

11.7 HENGRUI Medical

11.7.1 HENGRUI Medical Company Details

11.7.2 HENGRUI Medical Business Overview

11.7.3 HENGRUI Medical Transarterial Radioembolization (TARE) Introduction

11.7.4 HENGRUI Medical Revenue in Transarterial Radioembolization (TARE) Business (2020-2025)

11.7.5 HENGRUI Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Boston Scientific Corporation

Terumo Corporation

HENGRUI Medical

List of Tables

Table 1. Global Transarterial Radioembolization (TARE) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Microspheres

Table 3. Key Players of Particles

Table 4. Key Players of Drug-eluting Beads (DEBs)

Table 5. Key Players of Radio-Embolic Microspheres

Table 6. Global Transarterial Radioembolization (TARE) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Transarterial Radioembolization (TARE) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Transarterial Radioembolization (TARE) Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Transarterial Radioembolization (TARE) Market Share by Region (2020-2025)

Table 10. Global Transarterial Radioembolization (TARE) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Transarterial Radioembolization (TARE) Market Share by Region (2026-2031)

Table 12. Transarterial Radioembolization (TARE) Market Trends

Table 13. Transarterial Radioembolization (TARE) Market Drivers

Table 14. Transarterial Radioembolization (TARE) Market Challenges

Table 15. Transarterial Radioembolization (TARE) Market Restraints

Table 16. Global Transarterial Radioembolization (TARE) Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Transarterial Radioembolization (TARE) Market Share by Players (2020-2025)

Table 18. Global Top Transarterial Radioembolization (TARE) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transarterial Radioembolization (TARE) as of 2024)

Table 19. Ranking of Global Top Transarterial Radioembolization (TARE) Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Transarterial Radioembolization (TARE) Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Transarterial Radioembolization (TARE), Headquarters and Area Served

Table 22. Global Key Players of Transarterial Radioembolization (TARE), Product and Application

Table 23. Global Key Players of Transarterial Radioembolization (TARE), Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Transarterial Radioembolization (TARE) Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Transarterial Radioembolization (TARE) Revenue Market Share by Type (2020-2025)

Table 27. Global Transarterial Radioembolization (TARE) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Transarterial Radioembolization (TARE) Revenue Market Share by Type (2026-2031)

Table 29. Global Transarterial Radioembolization (TARE) Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Transarterial Radioembolization (TARE) Revenue Market Share by Application (2020-2025)

Table 31. Global Transarterial Radioembolization (TARE) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Transarterial Radioembolization (TARE) Revenue Market Share by Application (2026-2031)

Table 33. North America Transarterial Radioembolization (TARE) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Transarterial Radioembolization (TARE) Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Transarterial Radioembolization (TARE) Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Transarterial Radioembolization (TARE) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Transarterial Radioembolization (TARE) Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Transarterial Radioembolization (TARE) Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Transarterial Radioembolization (TARE) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Transarterial Radioembolization (TARE) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Transarterial Radioembolization (TARE) Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Transarterial Radioembolization (TARE) Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Transarterial Radioembolization (TARE) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2026-2031) & (US$ Million)

Table 48. Sirtex Medical Company Details

Table 49. Sirtex Medical Business Overview

Table 50. Sirtex Medical Transarterial Radioembolization (TARE) Product

Table 51. Sirtex Medical Revenue in Transarterial Radioembolization (TARE) Business (2020-2025) & (US$ Million)

Table 52. Sirtex Medical Recent Development

Table 53. Merit Medical Company Details

Table 54. Merit Medical Business Overview

Table 55. Merit Medical Transarterial Radioembolization (TARE) Product

Table 56. Merit Medical Revenue in Transarterial Radioembolization (TARE) Business (2020-2025) & (US$ Million)

Table 57. Merit Medical Recent Development

Table 58. Cook Medical Company Details

Table 59. Cook Medical Business Overview

Table 60. Cook Medical Transarterial Radioembolization (TARE) Product

Table 61. Cook Medical Revenue in Transarterial Radioembolization (TARE) Business (2020-2025) & (US$ Million)

Table 62. Cook Medical Recent Development

Table 63. BTG Medical Company Details

Table 64. BTG Medical Business Overview

Table 65. BTG Medical Transarterial Radioembolization (TARE) Product

Table 66. BTG Medical Revenue in Transarterial Radioembolization (TARE) Business (2020-2025) & (US$ Million)

Table 67. BTG Medical Recent Development

Table 68. Boston Scientific Corporation Company Details

Table 69. Boston Scientific Corporation Business Overview

Table 70. Boston Scientific Corporation Transarterial Radioembolization (TARE) Product

Table 71. Boston Scientific Corporation Revenue in Transarterial Radioembolization (TARE) Business (2020-2025) & (US$ Million)

Table 72. Boston Scientific Corporation Recent Development

Table 73. Terumo Corporation Company Details

Table 74. Terumo Corporation Business Overview

Table 75. Terumo Corporation Transarterial Radioembolization (TARE) Product

Table 76. Terumo Corporation Revenue in Transarterial Radioembolization (TARE) Business (2020-2025) & (US$ Million)

Table 77. Terumo Corporation Recent Development

Table 78. HENGRUI Medical Company Details

Table 79. HENGRUI Medical Business Overview

Table 80. HENGRUI Medical Transarterial Radioembolization (TARE) Product

Table 81. HENGRUI Medical Revenue in Transarterial Radioembolization (TARE) Business (2020-2025) & (US$ Million)

Table 82. HENGRUI Medical Recent Development

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

Table 86. Authors List of This Report

List of Figures

Figure 1. Transarterial Radioembolization (TARE) Picture

Figure 2. Global Transarterial Radioembolization (TARE) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Transarterial Radioembolization (TARE) Market Share by Type: 2024 VS 2031

Figure 4. Microspheres Features

Figure 5. Particles Features

Figure 6. Drug-eluting Beads (DEBs) Features

Figure 7. Radio-Embolic Microspheres Features

Figure 8. Global Transarterial Radioembolization (TARE) Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Transarterial Radioembolization (TARE) Market Share by Application: 2024 VS 2031

Figure 10. Uterine Fibroid Embolization Case Studies

Figure 11. Prostatic Artery Embolization Case Studies

Figure 12. Liver Tumor Embolization Case Studies

Figure 13. Trauma Embolization Case Studies

Figure 14. Others Case Studies

Figure 15. Transarterial Radioembolization (TARE) Report Years Considered

Figure 16. Global Transarterial Radioembolization (TARE) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Transarterial Radioembolization (TARE) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Transarterial Radioembolization (TARE) Market Share by Region: 2024 VS 2031

Figure 19. Global Transarterial Radioembolization (TARE) Market Share by Players in 2024

Figure 20. Global Top Transarterial Radioembolization (TARE) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transarterial Radioembolization (TARE) as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Transarterial Radioembolization (TARE) Revenue in 2024

Figure 22. North America Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Transarterial Radioembolization (TARE) Market Share by Country (2020-2031)

Figure 24. United States Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Transarterial Radioembolization (TARE) Market Share by Country (2020-2031)

Figure 28. Germany Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Transarterial Radioembolization (TARE) Market Share by Region (2020-2031)

Figure 36. China Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Transarterial Radioembolization (TARE) Market Share by Country (2020-2031)

Figure 44. Mexico Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Transarterial Radioembolization (TARE) Market Share by Country (2020-2031)

Figure 48. Turkey Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Transarterial Radioembolization (TARE) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Sirtex Medical Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2020-2025)

Figure 52. Merit Medical Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2020-2025)

Figure 53. Cook Medical Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2020-2025)

Figure 54. BTG Medical Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2020-2025)

Figure 55. Boston Scientific Corporation Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2020-2025)

Figure 56. Terumo Corporation Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2020-2025)

Figure 57. HENGRUI Medical Revenue Growth Rate in Transarterial Radioembolization (TARE) Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions